Transcript Presentation-standard

Young people, substance
misuse and PHE
Jez Stannard, Senior programme manager (alcohol, drugs and tobacco division)
summary
-
Explain what we know about prevalence of use
-
Summarise the advice PHE gives to LAs around the YP substance misuse
prevention and treatment agenda
-
Set the scene around specialist substance misuse services (treatment) and
the data from the latest annual report – including some London specific
data
2
Presentation title - edit in Header and Footer
Prevalence
- Smoking, Drinking and Drug Use survey (now biennial)
shows a continued national decrease in prevalence
amongst 11-15 year olds
- ….But it has its limitations
- What about the What About YOUth survey?
- Unfortunately this does mean that we don’t have reliable,
comprehensive local level prevalence data
3
Presentation title - edit in Header and Footer
SDD survey – key data
-
Around 240,000 pupils aged between 11 and 15 had drunk alcohol in the
past week, 180,000 had taken drugs in the last month, and 310,000 had
taken drugs in the last year
-
38% had tried alcohol at least once (lowest proportion since the survey
began recording alcohol use in 1988)
-
Drug use declined between 2001 and 2010 and since 2010 the decline has
slowed. In 2014
-
15% had ever taken drugs, 10% had taken drugs in the last year, and 6%
had taken drugs in the last month. This is the lowest proportion since the
survey started recording drug use in 1998
-
Pupils were more likely to have taken cannabis than any other drug. 2.5%
of pupils said that they had ever taken NPS
-
Pupils who had truanted or been excluded from school were more likely
than other pupils to say that they took drugs once a month or more or that
they had taken Class A drugs in the last year
4
Presentation title - edit in Header and Footer
We mainly provide advice to LAs through the PHE JSNA
commissioning prompts
5
Presentation title - edit in Header and Footer
•
Main advice PHE gives to LA commissioners is via the annual JSNA
commissioning prompts: http://www.nta.nhs.uk/healthcare-JSNA.aspx
•
Covers:
• Universal and targeted evidence base prevention
• Specialist treatment
•
On universal:
• “Approaches that focus on reducing risk and increasing resilience are more
effective than those that focus on topic specific programmes and interventions”
• We commission Mentor-ADEPIS for schools and prevention practitioners
http://mentor-adepis.org/
• On targeted:
•
Link to other vulnerable groups
• On specialist
•
6
Detailed advice on what should be commissioned
Presentation title - edit in Header and Footer
PHE published the 2015-16 young people’s annual
treatment stats on 12.01.17
7
Presentation title - edit in Header and Footer
•
Declining no’s of YP entering treatment (17,077, a drop of 1,272 or 7%
compared to 2014-15). Continues a downward trend, year-on-year, since a
peak of 24,053 in 2008-09
•
The most common presenting substance continues to be cannabis.
More than four-fifths (87%) of young people had a problem with t compared
to 86% in 2014-15. The numbers in treatment for cannabis as a primary
substance have been on an upward trend since 2005-06, although numbers
have dipped slightly in the last two years
•
Alcohol is the next most commonly cited problematic substance with
just under half the young people in treatment (48%) seeking help for its
misuse during 2015-16. However, numbers in treatment for alcohol
problems have been declining steadily in recent years and this figure is
much lower than the two-thirds (67%) reported in 2009-10
8
Presentation title - edit in Header and Footer
•
Other substances:
-
1,605 cited problematic ecstasy use (9%)
-
1,477 cocaine (9%)
-
1,152 amphetamine (7%)
-
1,056 (6%) with concerns around the use of new psychoactive substances (NPS)
•
Not seeing no’s coming into treatment around NPS that perhaps we
would expect
•
Main referral routes are via education provision (28%), youth justice
services (26%), and children’s social care (14%). The proportion of referrals
from the youth justice system have declined in recent years while the
proportion of referrals from education has increased
9
Presentation title - edit in Header and Footer
Link with other vulnerabilities
•
Majority of young people in treatment have multiple risks/vulnerabilities:
- other problems or vulnerabilities (i.e. mental health problems, being
‘looked after’ or not being in education, training or employment )
- wider factors that can impact on substance use (i.e. offending, selfharming, experiencing sexual exploitation or domestic abuse)
- NDTMS collects 7 vulnerability items:
83% have two or more vulnerabilities
59% have three or more
38% have 2 or more
- Sexual exploitation: Six per cent (6%) in 15-16 compared to 5% in 201415. Significantly higher among females (14%) than males (just over 1%)
10
Presentation title - edit in Header and Footer
Some London specific data
2012-13
2013-14
2014-15
2015-16
3,555
3,524
3,363
3,120
-
-1%
-5%
-7%
2012-13
2013-14
2014-15
2015-16
20,718
19,788
18,949
17,593
-
-4%
-4%
-7%
London
% change compared to previous year
National
% change compared to previous year
No’s in treatment in London
have been declining at roughly
the same rate as nationally
11
Presentation title - edit in Header and Footer
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
London
National
(marginally) more cannabis and
nicotine. Less alcohol, ecstasy,
cocaine, amphetamine and NPS
than nationally
12
Presentation title - edit in Header and Footer
Crack
NPS
Opiates
Amphetamines
Other
Cocaine
Solvents
Ecstasy
Nicotine
Alcohol
Cannabis
0%
13
London
Presentation title - edit in Header and Footer
Young people in treatment in
London have less vulnerability
factors than nationally
High risk alcohol user
Child in Need
Sexual exploitation
Injecting
Opiate or crack user
Housing problems
Parental status / pregnant
National
Child Protection Plan
Self Harm
Looked After Child
Mental Health problem
Domestic Abuse
Affected by others'
substance misuse
NEET
Anti-social behaviour /
criminal act
Poly drug user
Early onset
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Things that are in the pipeline
•
New government national Drug Strategy is imminent (the last one was 2010
– 2015). We fully expect prevention and treatment to be centre stage
(Link to last is https://www.gov.uk/government/publications/drug-strategy-2010)
•
New UK guidelines on clinical management of drug misuse and
dependence (updating the 2007 edition) – covers young people
(Link to last is http://www.nta.nhs.uk/uploads/clinical_guidelines_2007.pdf)
•
NICE activity updating guidelines on prevention, and alcohol school based
interventions
CONTACT: [email protected]
020 3682 0532
14
Presentation title - edit in Header and Footer